Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Big pharma Sanofi agreed Tuesday to pay $25.2 million to resolve charges that it paid bribes across the Middle East and in Kazakhstan to win business.
The SEC said Sanofi violated the FCPA’s books and records and internal accounting controls provisions.… Continue Reading
French pharma Sanofi said Wednesday the DOJ has closed an FCPA investigation that started four years ago.
The company said it heard from the DOJ in February.
But Sanofi said it is still cooperating with the SEC’s “review of the allegations.”… Continue Reading
Big Pharma Sanofi-Aventis was awarded $38.7 million Thursday as its share of a $465 million False Claims Act settlement by Mylan for knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed to Medicaid.… Continue Reading
Here’s some non-U.S. news from the past year about anti-corruption enforcement against individuals:
GSK’s former head of China operations, Mark Reilly, a UK national, was given a three-year prison sentence.… Continue Reading
A former paralegal for Sanofi claims she was fired in September in retaliation for revealing a huge scheme involving kickbacks to doctors that violated U.S. federal law.
Diane Ponte filed the lawsuit in New Jersey Superior Court in Newark.… Continue Reading
An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.
Poland’s anti-corruption bureau charged two women with bribery. Prosecutors said they gave a health fund official a tourist trip worth more than $1,000 in exchange for backing the sale of a particular drug, Reuters said.… Continue Reading
Sanofi said Monday it has self reported the allegations to the U.S.… Continue Reading
Two former employees of Sanofi-Aventis were convicted by a German court on bribery charges 10 months ago and the Paris-based pharma was fined €28 million ($39 million), according to a Reuters report last week.… Continue Reading
Image courtesy of GlaxoSmithKlineA police investigation in China has found that drugmaker GlaxoSmithKline’s alleged bribery of doctors ‘was coordinated by the British company and was not the work of individual employees,’ according to a report Tuesday by Reuters.… Continue Reading
Pharmas have told their sales teams to halt all activity in China to avoid being caught in the nationwide “enforcement storm,” according to the Guangdong-based Yangcheng Evening News.
“It is rumored that police in plain clothes are patrolling in hospitals; drug sales representatives will be fined 500 yuan ($81) and regional sales managers 1000 yuan ($162) once being caught in hospitals,” an unidentified sales representative told the paper.… Continue Reading
China state media reported Saturday that French drugmaker Sanofi SA is under investigation for allegedly bribing doctors to increase sales.
The Xinhua news agency said more than 500 Chinese doctors are suspected of accepting bribes from the company.… Continue Reading
Recent turbulence in China for drug makers follows big problems for members of the industry in the United States, where they’ve paid billions in criminal fines and civil penalties.
Here’s a quick rundown of their U.S.… Continue Reading
